The opioid growth factor (OGF) and low dose naltrexone (LDN) suppress human ovarian cancer progression in mice
| Autor: | Donahue, Renee N., McLaughlin, Patricia J., Zagon, Ian S. |
|---|---|
| Zdroj: | In Gynecologic Oncology 2011 122(2):382-388 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect